Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Accuray announces launch of new CyberKnife S7 System » 08:59
06/17/20
06/17
08:59
06/17/20
08:59
ARAY

Accuray

$2.27 /

-0.025 (-1.09%)

Accuray announces the…

Accuray announces the company has launched the CyberKnife S7 System, which it calls "an innovative device combining speed, advanced precision, and real-time artificial intelligence-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery and stereotactic body radiation therapy treatments - in as little as 15 minutes." Joshua Levine, president and CEO at Accuray, said, "With the introduction of the CyberKnife S7 System, Accuray is continuing its legacy of innovation. We believe this new system will make it easier for Geisinger clinicians to successfully deliver SRS and SBRT and achieve their patient-first treatment objectives, a priority for their team and ours."

ShowHide Related Items >><<
ARAY Accuray
$2.27 /

-0.025 (-1.09%)

ARAY Accuray
$2.27 /

-0.025 (-1.09%)

04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
ARAY Accuray
$2.27 /

-0.025 (-1.09%)

Over a month ago
Earnings
Accuray withdraws FY20 guidance » 16:09
04/28/20
04/28
16:09
04/28/20
16:09
ARAY

Accuray

$2.03 /

+0.15 (+7.98%)

The company said,…

The company said, "Given the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry, Accuray believes it is prudent to withdraw its previous full fiscal year 2020 financial guidance regarding revenue and adjusted EBITDA. The company is carefully monitoring the pandemic and the impact on its business; however, given the uncertainty regarding the pandemic's spread, duration, and impact, the company is currently unable to predict the extent to which the COVID-19 pandemic will impact its future operations and financial results."

ShowHide Related Items >><<
ARAY Accuray
$2.03 /

+0.15 (+7.98%)

04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
Earnings
Accuray reports Q3 EPS 3c, consensus (4c) » 16:08
04/28/20
04/28
16:08
04/28/20
16:08
ARAY

Accuray

$2.03 /

+0.15 (+7.98%)

Reports Q3 revenue…

Reports Q3 revenue $99.5M, consensus $97.26M.

ShowHide Related Items >><<
ARAY Accuray
$2.03 /

+0.15 (+7.98%)

04/17/20 JPMorgan
Varian Medical price target lowered to $90 from $100 at JPMorgan
01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
Recommendations
Varian Medical price target lowered to $90 from $100 at JPMorgan » 08:47
04/17/20
04/17
08:47
04/17/20
08:47
VAR

Varian Medical

$108.76 /

-0.87 (-0.79%)

, ARAY

Accuray

$1.70 /

-0.13 (-7.10%)

JPMorgan analyst Tycho…

JPMorgan analyst Tycho Peterson lowered the firm's price target on Varian Medical (VAR) to $90 from $100 and keeps an Underweight rating on the shares. The analyst says a survey of 42 hospital CFOs, radiation department heads and radiation oncologists, as well as the near-term impact from COVID-19, reinforce an Underweight thesis on both Varian and Accuray (ARAY). The analyst sees reduced visibility into future customer demand.

ShowHide Related Items >><<
VAR Varian Medical
$108.76 /

-0.87 (-0.79%)

04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from In Line at Evercore ISI
04/09/20 Evercore ISI
Varian Medical downgraded to Underperform from Outperform at Evercore ISI
04/07/20 Piper Sandler
Varian Medical initiated with an Overweight at Piper Sandler
04/01/20 Goldman Sachs
Varian Medical downgraded to Neutral from Buy at Goldman Sachs
ARAY Accuray
$1.70 /

-0.13 (-7.10%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
Over a quarter ago
Hot Stocks
Accuray's TomoTherapy System shows improved efficacy in rectal cancer studies » 07:39
02/05/20
02/05
07:39
02/05/20
07:39
ARAY

Accuray

$3.61 /

-0.15 (-3.99%)

Accuray announced that…

Accuray announced that two new studies demonstrate the benefits of the TomoTherapy System in the treatment of advanced rectal cancer. Patients enrolled in the two studies received simultaneous daily radiation and a targeted radiation boost over a 25-day time period. The study investigators found that the TomoTherapy platform enabled the delivery of a high dose of radiation, directly to the tumor, through the integrated boost of radiation, while minimizing radiation to organs in close proximity to the targeted tumor. As a result, patients in the studies experienced improved treatment results and reduced side effects. These study outcomes compare favorably to conventional radiotherapy, based on results from other studies.The study published in the Journal of Cancer Research and Clinical Oncology, found treatment with TomoHelical is safe, with low rates of severe toxicity , and radiation delivered with helical TomoTherapy following daily imaging with the platform's integrated imaging capabilities allowed for the reduction of treatment margins around the tumor, so less normal tissue was irradiated. The four-year outcomes showed local tumor control and disease-free survival rates of 88.4% and 74.6%, respectively.

ShowHide Related Items >><<
ARAY Accuray
$3.61 /

-0.15 (-3.99%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
Hot Stocks
Fly Intel: After Hours Movers » 18:32
01/28/20
01/28
18:32
01/28/20
18:32
MTSI

Macom

$26.22 /

-0.97 (-3.57%)

, ARAY

Accuray

$3.77 /

+ (+0.00%)

, MXIM

Maxim Integrated

$62.11 /

+1.8 (+2.98%)

, CMRE

Costamare

$8.26 /

+0.23 (+2.86%)

, MKSI

MKS Instruments

$113.32 /

+4.73 (+4.36%)

, AAPL

Apple

$317.76 /

+8.83 (+2.86%)

, SYK

Stryker

$214.23 /

-0.39 (-0.18%)

, CNAT

Conatus

$0.41 /

+0.0119 (+3.01%)

, XLNX

Xilinx

$98.58 /

+1.52 (+1.57%)

, CHRW

C.H. Robinson

$77.89 /

-0.57 (-0.73%)

, EBAY

eBay

$36.22 /

+0.74 (+2.09%)

, AMD

AMD

$50.51 /

+1.25 (+2.54%)

, MRCY

Mercury Systems

$78.13 /

+2.61 (+3.46%)

, TRMK

Trustmark

$33.30 /

+0.1 (+0.30%)

, SBUX

Starbucks

$88.60 /

-0.14 (-0.16%)

, BHVN

Biohaven Pharmaceutical

$56.32 /

+3.015 (+5.66%)

, CERS

Cerus

$4.15 /

-0.345 (-7.68%)

, ESTA

Establishment Labs

$26.44 /

+0.09 (+0.34%)

, MTCH

Match Group

$83.95 /

-0.4 (-0.47%)

UP AFTER EARNINGS: Macom…

UP AFTER EARNINGS: Macom (MTSI) up 13.4%... Accuray (ARAY) up 10.1%... Maxim Integrated (MXIM) up 3.3%... Costamare (CMRE) up 2.8%... MKS Instruments (MKSI) up 2.0%... Apple (AAPL) up 1.1%... Stryker (SYK) up 0.9%. ALSO HIGHER: Conatus Pharma (CNAT) up 20.0% after entering merger with Histogen. DOWN AFTER EARNINGS: Xilinx (XLNX) down 8.7%... CH Robinson (CHRW) down 7.2%... eBay (EBAY) down 5.2%... AMD (AMD) down 3.9%... Mercury Systems (MRCY) down 1.9%... Trustmark (TRMK) down 1.8%... Starbucks (SBUX) down 1.0%. ALSO LOWER: Biohaven (BHVN) down 10.7% after equity offering... Cerus (CERS) down 5.8% after equity offering... Establishment Labs (ESTA) down 3.4% after equity offering... Match Group (MTCH) down 1.2% after CEO transition. Movers as of 18:15ET.

ShowHide Related Items >><<
MTSI Macom
$26.22 /

-0.97 (-3.57%)

01/15/20 Piper Sandler
Piper sees 2020 as 'major recovery year' for Semiconductors
12/03/19 Rosenblatt
Lumentum, Maxim, Macom to benefit from ZTE, Huawei procurement, says Rosenblatt
11/18/19 Northland
Macom price target raised to $30 from $22.50 at Northland
11/14/19 DA Davidson
Macom price target raised to $24 from $18 at DA Davidson
ARAY Accuray
$3.77 /

+ (+0.00%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
01/29/19 Lake Street
Lake Street encourages investors to revisit Accuray shares
MXIM Maxim Integrated
$62.11 /

+1.8 (+2.98%)

01/16/20
Fly Intel: Top five analyst downgrades
01/16/20 Barclays
AMD price target raised to $50 from $32 at Barclays
01/16/20 Barclays
Barclays downgrades Maxim Integrated to Underweight on lack of growth drivers
01/16/20 Barclays
Maxim Integrated downgraded to Underweight from Equal Weight at Barclays
CMRE Costamare
$8.26 /

+0.23 (+2.86%)

11/01/19 Citi
Costamare downgraded to Sell from Neutral at Citi
10/24/19 B. Riley FBR
Strong Costamare results a good sign for Global Ship Lease, says B. Riley FBR
MKSI MKS Instruments
$113.32 /

+4.73 (+4.36%)

01/27/20 Deutsche Bank
MKS Instruments price target raised to $130 from $115 at Deutsche Bank
01/21/20 Citi
Citi boosts Lam, MKS targets and opens 'Positive Catalyst Watches'
12/11/19
Citi remains long Semiconductor Capital Equipment stocks into 2020
10/25/19 DA Davidson
MKS Instruments price target raised to $125 from $100 at DA Davidson
AAPL Apple
$317.76 /

+8.83 (+2.86%)

01/27/20 JPMorgan
JPMorgan cautions against 'high bar of investor expectations' into Apple print
01/27/20 Deutsche Bank
Apple setup 'bodes poorly' after recent stock rally, says Deutsche Bank
01/27/20 RBC Capital
Apple Q1 estimates are 'reasonable', says RBC Capital
01/27/20 BTIG
Intelligent Systems initiated with a Buy at BTIG
SYK Stryker
$214.23 /

-0.39 (-0.18%)

01/07/20 SunTrust
Stryker initiated with a Hold at SunTrust
01/07/20 Piper Sandler
Stryker downgraded to Neutral from Overweight at Piper Sandler
12/30/19 BTIG
Stryker price target raised to $236 from $228 at BTIG
12/24/19 Jefferies
Wright Medical downgraded to Hold from Buy at Jefferies
CNAT Conatus
$0.41 /

+0.0119 (+3.01%)

03/26/19
Conatus downgraded to Neutral on emricasan uncertainty at Roth Capital
03/26/19 Roth Capital
Conatus downgraded to Neutral from Buy at Roth Capital
03/22/19 Stifel
Conatus' greater than 50% decline on trial failure warranted, says Stifel
03/22/19 H.C. Wainwright
Conatus downgraded to Neutral from Buy at H.C. Wainwright
XLNX Xilinx
$98.58 /

+1.52 (+1.57%)

01/16/20 Mizuho
Xilinx downgraded to Neutral from Buy at Mizuho
01/10/20 BofA
Xilinx downgraded to Underperform from Neutral at BofA
01/10/20 BofA
Xilinx downgraded to Underperform from Neutral at BofA
12/31/19 Rosenblatt
AMD, Micron, Xilinx top Semiconductor picks at Rosenblatt going into 2020
CHRW C.H. Robinson
$77.89 /

-0.57 (-0.73%)

01/15/20 Susquehanna
Susquehanna sees higher multiple, upgrades C.H. Robinson to Positive
01/15/20 Susquehanna
C.H. Robinson upgraded to Positive from Neutral at Susquehanna
01/15/20 Barclays
C.H. Robinson upgraded to Overweight from Equal Weight at Barclays
01/07/20 Wolfe Research
Wolfe positive on Transports after shipper survey, upgrades three names
EBAY eBay
$36.22 /

+0.74 (+2.09%)

01/28/20 Wells Fargo
Shortened holiday calendar likely bigger headwind for eBay, says Wells Fargo
01/28/20 Susquehanna
eBay has potential for value creation, says Susquehanna
01/17/20
Fly Intel: Top five analyst downgrades
01/17/20 Wells Fargo
Wells Fargo downgrades eBay to Underweight, cuts target to $32 from $45
AMD AMD
$50.51 /

+1.25 (+2.54%)

01/28/20 Lynx
Lynx would be seller of Intel at current levels, cautious on AMD ahead of report
01/27/20 Susquehanna
AMD backdrop should help meet expectations, says Susquehanna
01/24/20 Morgan Stanley
Intel took 'some of the bear case off the table' with guide, says Morgan Stanley
01/24/20 BofA
Intel price target raised to $75 from $70 at BofA
MRCY Mercury Systems
$78.13 /

+2.61 (+3.46%)

12/04/19 Baird
Mercury Systems should be added to on any pullbacks, says Baird
08/16/19 Goldman Sachs
Mercury Systems initiated with a Neutral at Goldman Sachs
08/16/19 Goldman Sachs
Mercury Systems initiated with a Neutral at Goldman Sachs
08/09/19 BofA
Mercury Systems upgraded to Neutral from Underperform at BofA/Merrill
TRMK Trustmark
$33.30 /

+0.1 (+0.30%)

03/19/19 Keefe Bruyette
Trustmark downgraded to Underperform from Market Perform at Keefe Bruyette
SBUX Starbucks
$88.60 /

-0.14 (-0.16%)

01/27/20 Guggenheim
Guggenheim says Starbucks has most China exposure among restaurants covered
01/23/20 Cleveland Research
Starbucks' Americas comp running ahead of consensus, says Cleveland Research
01/23/20 Gordon Haskett
Starbucks drivers in place to maintain sales momentum, says Gordon Haskett
01/09/20
Fly Intel: Top five analyst upgrades
BHVN Biohaven Pharmaceutical
$56.32 /

+3.015 (+5.66%)

12/23/19 Piper Sandler
Ubrelvy's label 'clearly bodes very well' for Biohaven's rimegepant, says Piper
12/17/19 Piper Sandler
Biohaven now has second, complementary CGRP product, says Piper Jaffray
12/06/19 SVB Leerink
Biohaven price target raised to $64 from $62 at SVB Leerink
12/06/19 Piper Sandler
Biohaven models should start adding value for Alzheimer's, says Piper Jaffray
CERS Cerus
$4.15 /

-0.345 (-7.68%)

01/23/20 Cowen
Cowen encouraged by Cerus data on Intercept in light of new coronavirus
11/13/19 BTIG
Cerus upgraded to Buy from Neutral at BTIG
08/28/19
Fly Intel: Top five analyst initiations
08/27/19 Stifel
Cerus initiated with a Buy at Stifel
ESTA Establishment Labs
$26.44 /

+0.09 (+0.34%)

01/03/20 BTIG
Zimmer Biomet, Staar Surgical, ViewRay among top 2020 picks at BTIG
07/24/19 Wells Fargo
Allergan recall to benefit Establishment and Sientra, says Wells Fargo
07/12/19 Wells Fargo
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
07/11/19 Wells Fargo
Market right in seeing rebate news as risk to pharmaceuticals, says Wells Fargo
MTCH Match Group
$83.95 /

-0.4 (-0.47%)

01/28/20 Barclays
IAC price target raised to $290 from $254 at Barclays
01/17/20 Wells Fargo
Match Group price target raised to $100 from $85 at Wells Fargo
01/17/20 UBS
Match Group downgraded to Neutral from Buy on valuation at UBS
01/17/20 UBS
Match Group downgraded to Neutral from Buy at UBS
  • 29
    Jan
  • 30
    Jan
Hot Stocks
Accuray raises FY20 adj. EBITDA view to $21M-$26M from $19M-$24M » 16:09
01/28/20
01/28
16:09
01/28/20
16:09
ARAY

Accuray

$3.78 /

+0.01 (+0.27%)

Includes approximately…

Includes approximately $1M of the company's share of expected loss from the joint venture operations in China.

ShowHide Related Items >><<
ARAY Accuray
$3.78 /

+0.01 (+0.27%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
01/29/19 Lake Street
Lake Street encourages investors to revisit Accuray shares
Earnings
Accuray backs FY20 revenue view $410M-$420M, consensus $412.77M » 16:08
01/28/20
01/28
16:08
01/28/20
16:08
ARAY

Accuray

$3.78 /

+0.01 (+0.27%)

The company expects to…

The company expects to generate revenue growth during the second half of fiscal year 2020 compared to the second half of the prior fiscal year.

ShowHide Related Items >><<
ARAY Accuray
$3.78 /

+0.01 (+0.27%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
01/29/19 Lake Street
Lake Street encourages investors to revisit Accuray shares
Earnings
Accuray reports Q2 EPS 12c with gain, consensus (7c) » 16:07
01/28/20
01/28
16:07
01/28/20
16:07
ARAY

Accuray

$3.78 /

+0.01 (+0.27%)

Reports Q2 revenue…

Reports Q2 revenue $98.8M, consensus $97.73M. Net income included a non-cash, special gain of $13M related to the value of the company's capital contribution to the China joint venture in exchange for the company's 49% equity interest in the joint venture. This gain was recorded as non-operating, other income in the second quarter.

ShowHide Related Items >><<
ARAY Accuray
$3.78 /

+0.01 (+0.27%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
01/29/19 Lake Street
Lake Street encourages investors to revisit Accuray shares
Hot Stocks
Fly Intel: Pre-market Movers » 09:17
01/21/20
01/21
09:17
01/21/20
09:17
ARAY

Accuray

$3.27 /

-0.16 (-4.66%)

, HAL

Halliburton

$23.96 /

+0.15 (+0.63%)

, UBS

UBS

$13.13 /

-0.06 (-0.45%)

, TAL

TAL Education

$54.07 /

-2 (-3.57%)

, MDR

McDermott

$0.70 /

-0.0224 (-3.12%)

, ORGS

Orgenesis

$5.40 /

+0.36 (+7.14%)

, LVS

Las Vegas Sands

$74.07 /

+0.67 (+0.91%)

, LL

Lumber Liquidators

$9.35 /

+0.06 (+0.65%)

HIGHER: Accuray (ARAY),…

HIGHER: Accuray (ARAY), up 10% after BTIG analyst Marie Thibault upgraded shares to Buy from Neutral with a $9.50 price target. The analyst notes that the company's long-term revenue growth outlook of 8%-12% announced last week, driven in large part by the contribution from China, is "significantly higher" than its historical performance and the low-to-single digit growth anticipated by consensus. UP AFTER EARNINGS: Halliburton (HAL), up 1%. DOWN AFTER EARNINGS: UBS (UBS), down 4%... TAL Education (TAL), down 8%. ALSO LOWER: McDermott (MDR), down 14% after announcing that it has the support of more than two-thirds of all its funded debt creditors for a restructuring transaction that will equitize nearly all the company's funded debt, eliminating over $4.6B of debt. The restructuring transaction will be implemented through a prepackaged Chapter 11 process that will be financed by a debtor-in-possession financing facility of $2.81B... Las Vegas Sands (LVS), down 5% after Morgan Stanley analyst Thomas Allen downgraded the stock to Equal Weight from Overweight. He continues to see the stock as "the mass market play on Macau" and his Macau mass market growth forecast for 2020 trails what Consensus Metrix suggests is the U.S. analyst forecast average... Orgenesis (ORGS), down 7% after announcing it has entered into a definitive securities purchase agreement for the sale of 2,200,000 shares of the company's common stock in a private placement at a purchase price of $4.20 per share and warrants to purchase up to 1,000,000 shares of common stock at an exercise price of $5.50 per share... Lumber Liquidators (LL), down 6% after Morgan Stanley analyst Simeon Gutman downgraded shares to Underweight from Equal Weight with a price target of $5, down from $9.

ShowHide Related Items >><<
ARAY Accuray
$3.27 /

-0.16 (-4.66%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
01/29/19 Lake Street
Lake Street encourages investors to revisit Accuray shares
HAL Halliburton
$23.96 /

+0.15 (+0.63%)

01/13/20 Bernstein
Bernstein initiates coverage of Global Oil Services sector
01/13/20 Bernstein
Halliburton initiated with an Underperform at Bernstein
01/06/20 Scotiabank
Scotiabank rearranges U.S. Oilfield Services ratings with eight changes
01/06/20 Scotiabank
Halliburton upgraded to Outperform from Sector Perform at Scotiabank
UBS UBS
$13.13 /

-0.06 (-0.45%)

10/22/19 Evercore ISI
Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative
10/22/19 Evercore ISI
UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI
09/10/19 Kepler Cheuvreux
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
Fly Intel: Top analyst downgrade
TAL TAL Education
$54.07 /

-2 (-3.57%)

01/16/20 TH Data Capital
New Oriental Education price target raised to $160 from $130 at TH Data Capital
01/09/20 Macquarie
TAL Education upgraded to Outperform from Neutral at Macquarie
01/08/20 Macquarie
TAL Education upgraded to Outperform from Neutral at Macquarie
11/01/19
Fly Intel: Top five analyst upgrades
MDR McDermott
$0.70 /

-0.0224 (-3.12%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
ORGS Orgenesis
$5.40 /

+0.36 (+7.14%)

09/26/19 Benchmark
Orgenesis initiated with a Speculative Buy at Benchmark
LVS Las Vegas Sands
$74.07 /

+0.67 (+0.91%)

01/21/20 Morgan Stanley
Las Vegas Sands downgraded to Equal Weight from Overweight at Morgan Stanley
01/16/20 Standpoint Research
Las Vegas Sands downgraded to Hold from Buy at Standpoint Research
01/13/20 Goldman Sachs
Wynn Resorts upgraded to Conviction Buy from Buy at Goldman Sachs
01/08/20 Stifel
Eldorado Resorts named top Gaming & Leisure idea for 2020 at Stifel
LL Lumber Liquidators
$9.35 /

+0.06 (+0.65%)

01/21/20 Morgan Stanley
Lumber Liquidators downgraded to Underweight from Equal Weight at Morgan Stanley
12/04/19 Wedbush
Floor & Decor to see earnings boost from tariff exclusion, says Wedbush
09/13/19 Raymond James
Lumber Liquidators price target raised to $14 from $10 at Raymond James
06/05/19 Raymond James
Tariffs creating new 'headaches' for Lumber Liquidators, says Raymond James

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.